AT
Amalus Therapeutics develops technologies for precise tissue remodeling, aiming to restore or improve organ function. Their platform focuses on engineering biomaterials and cellular therapies to reshape damaged tissues and enhance patient outcomes.
Updated 2 months ago
Funding
$542.1K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
BI
Funding rounds are not available yet.
Founders
Product
Features
- <problem></problem>
- <solution></solution>
- <features>
- </features>
- <target_audience></target_audience>